Publications by Dr Fareeda Coxon - ePrints

Browsing publications by Dr Fareeda Coxon.

Newcastle Authors	Title	Year
Dr Fareeda Coxon	Vandetanib plus gemcitabine versus placebo plus gemcitabine in locally advanced or metastatic pancreatic carcinoma (ViP): A prospective, randomised, double-blind, multicentre phase 2 trial	2017
Dr Sari Alhasan Dr Beate Haugk Laura Ogle Dr Gary Beale Anna Long et al.	Sulfatase-2: a prognostic biomarker and candidate therapeutic target in patients with pancreatic ductal adenocarcinoma	2016
Dr Fareeda Coxon Dr Kate Sumpter	Peri-operative chemotherapy +/- bevacizumab for resectable gastro-oesophageal adenocarcinoma: Results from the UK Medical Research Council randomised ST03 trial (ISRCTN 46020948)	2015
Dr Fareeda Coxon	Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): An open-label, phase 3 randomised controlled trial	2014
Dr Fareeda Coxon	Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial	2014
Dr Fareeda Coxon Dr Chris Plummer	Bevacizumab with peri-operative epirubicin, cisplatin and capecitabine (ECX) in localised gastro-oesophageal adenocarcinoma: a safety report	2013
Dr Fareeda Coxon Dr Mario Abinun Professor Andrew Cant	Identification of novel mutations in rankl as a cause of osteoclast-poor osteopetrosis	2007
Dr Fareeda Coxon	The use of palliative protracted infusion 5FU (PVI 5FU) as first line treatment for metastatic oesophageal and gastric cancer patients not suitable for standard cisplatin based combination treatment	2007
Dr Fareeda Coxon	Capecitabine (X) and oxaliplatin (O) combination chemotherapy in patients (pts) with advanced gall bladder or biliary tract cancer: A phase II study	2006
Dr Fareeda Coxon	In vitro study of osteoclast phenotypes in different types of human osteopetrosis	2006
Dr Fareeda Coxon	Pharmacoeconomic analysis of adjuvant oral capecitabine vs intravenous 5-FU/LV in Dukes' C colon cancer: the X-ACT trial	2006
Dr Fareeda Coxon	Randomised multicentre phase III study comparing capecitabine with fluorouracil and oxaliplatin with cisplatin in patients with advanced oesophagogastric cancer: The REAL 2 trial	2006